In particular, MND processes with slow progression, as in this case, cause less axonal degradation and thus a lower release of the axonal structural protein NfL into the blood, with normal serum NfL levels despite neurodegenerative pathology [22]. Here, PROS1 is linked to mild neurocognitive disorder.